期刊文献+

新诊断2型糖尿病患者血清网膜素-1与骨钙素水平的变化及其相关性研究 被引量:4

Study on serum omentin-1 and osteocalcin levels in newly diagnosed type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨新诊断T2DM患者血清网膜素-1与骨钙素水平的变化及其与IR的关系。方法选取2012年6月至2013年3月新诊断T2DM组55例及NGT组55名。ELISA测定血清网膜素-1及骨钙素水平,同时,测定血糖、胰岛素水平、HbA1c及血脂等指标,稳态模型评估胰岛素抵抗指数(HOMA-IR)和胰岛β细胞功能指数(HOMA-β)。结果 (1)T2DM组网膜素-1、骨钙素水平低于NGT组[(193.94±69.74)vs(429.73±78.12)ng/ml;(158.58±68.7)vs(377.74±73.38)pg/ml](P<0.05)。网膜素-1与骨钙素呈正相关(P<0.05)。(2)网膜素-1、骨钙素与FPG、2hPG、HbA1c、HOMA-IR及载脂蛋白B(ApoB)呈负相关。结论 T2DM患者网膜素-1与骨钙素水平均低于NGT者,且网膜素-1与骨钙素呈正相关,低水平的网膜素-1和骨钙素可能参与了T2DM的发生。 Objective To investigate the changes of serum omentin‐1 and osteocalcin levels in type 2 diabetes mellitus (T2DM ) patients and its relationship with insulin resistance. Methods 55 cases of newly diagnosed T2DM and 55 cases of normal glucose tolerance (NGT ) were selected from Jun ,2012 to Mar ,2013. Serum omentin‐1 and osteocalcin levels were measured by ELISA. The indicators of glucose , insulin ,HbA1 c ,and blood lipids were also determined. The index of insulin resistance was calculated by HOMA‐IR algorithm. Results (1) The serum levels of omentin‐1 and osteocalcin in newly diagnose T2DM group were lower than those in NGT group[(193.94 ± 69.74) vs (429.73 ± 78.12) ng/ml;(158.58 ± 68.7) vs (377.74 ± 73.38)pg/ml ,respectively ,P〈0.05]. The level of serum omentin‐1 was positively correlated with osteocalcin (P〈0.05). (2) The levels of serum omentin‐1 and osreocalcin were negatively correlated with FPG ,2 hPG ,HbA1c ,HOMA‐IR and ApoB. Conclusion The levels of serum omentin‐1 and osteocalcin decreased in newly diagnosed T 2DM and the level of serum omentin‐1 is positively correlated with osteocalcin. These findings suggested that low levels of omentin‐1 and osteocalcin may be involved in the occurrence of diabetes.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第5期405-408,共4页 Chinese Journal of Diabetes
基金 科技攻关项目(2013031301-9)
关键词 网膜素-1 骨钙素 糖尿病 2型 Osteocalcin
  • 相关文献

参考文献9

  • 1Xu Y, Wang LM, He J, et al. 2010 China Non communicable Disease Surveillance Group. Prevalence and control of diabetesin Chinese adults. JAMA, 2013,4 : 168118.
  • 2Schwetz V,Pieber T,Obermayer-Pietsch B. The endocrine role of the skeleton: background and clinical evidence. Eur J Endo- crinol, 2012,166 : 959-967.
  • 3Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell, 2007,130 : 456-469.
  • 4Ferron M, Hinoi E,Karsenty G, et al. Osteocalcin differentially regulates :cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA, 2008,105 : 5266-5270.
  • 5Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regula- tion and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clini Pratt, 2010,88 ; 29-33.
  • 6Chen X,Wu Y,Liu L, et al. Osteocalein is inversely associated with glucose levels in middle-aged Tibetan men with different degrees of glucose tolerance. Diabetes Metab Res Rev, 2013, 30; 475-482.
  • 7Pittas AG,Harris SS,Eliades M,et al. Association between se- rum osteocalcin and markers of metabolic phenotype. Clin En- docrinol Metab, 2009,94 : 827-832.
  • 8Xie H, Xie PL, Luo XP, et al. Omentin-1 exerts bone-sparing effect in ovariectomized mice. Osteoporos Int, 2012, 23: 1425-1436.
  • 9Wu SS, Liang QH, Liu Y, et al. Omentin-1 stimulates human osteoblast proliferation through PI3K/Akt signal pathway. Int J Endocrinol, 2013,2013 : 368970.

同被引文献43

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部